|
1
|
Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection.
|
Stroke
|
2005
|
2.13
|
|
2
|
Decreased perivascular fibrosis but not cardiac hypertrophy in ROCK1+/- haploinsufficient mice.
|
Circulation
|
2005
|
2.09
|
|
3
|
Regulation of endothelial nitric oxide synthase and postnatal angiogenesis by Rac1.
|
Circ Res
|
2008
|
2.04
|
|
4
|
Rapid nongenomic actions of thyroid hormone.
|
Proc Natl Acad Sci U S A
|
2006
|
1.79
|
|
5
|
Fingolimod provides long-term protection in rodent models of cerebral ischemia.
|
Ann Neurol
|
2010
|
1.62
|
|
6
|
Obesity increases vascular senescence and susceptibility to ischemic injury through chronic activation of Akt and mTOR.
|
Sci Signal
|
2009
|
1.43
|
|
7
|
Decreased vascular lesion formation in mice with inducible endothelial-specific expression of protein kinase Akt.
|
J Clin Invest
|
2006
|
1.31
|
|
8
|
Linking Notch signaling to ischemic stroke.
|
Proc Natl Acad Sci U S A
|
2008
|
1.28
|
|
9
|
TNF alpha and Fas mediate tissue damage and functional outcome after traumatic brain injury in mice.
|
J Cereb Blood Flow Metab
|
2007
|
1.23
|
|
10
|
Genetic analysis of the role of tumor necrosis factor receptors in functional outcome after traumatic brain injury in mice.
|
J Neurotrauma
|
2010
|
1.03
|
|
11
|
Reduced tissue damage and improved recovery of motor function after traumatic brain injury in mice deficient in complement component C4.
|
J Cereb Blood Flow Metab
|
2007
|
0.98
|
|
12
|
Mannose binding lectin gene deficiency increases susceptibility to traumatic brain injury in mice.
|
J Cereb Blood Flow Metab
|
2008
|
0.94
|
|
13
|
The functions of mTOR in ischemic diseases.
|
BMB Rep
|
2011
|
0.92
|
|
14
|
Prevalence of Plasmodium vivax VK210 and VK247 subtype in Myanmar.
|
Malar J
|
2010
|
0.89
|
|
15
|
Striatal neurons expressing full-length mutant huntingtin exhibit decreased N-cadherin and altered neuritogenesis.
|
Hum Mol Genet
|
2011
|
0.89
|
|
16
|
Detection of an antibody against Plasmodium vivax in residents of Gimpo-si, South Korea, using an indirect fluorescent antibody test.
|
Malar J
|
2011
|
0.89
|
|
17
|
AMP-activated protein kinase: implications on ischemic diseases.
|
BMB Rep
|
2012
|
0.88
|
|
18
|
Iron oxide-based nanomagnets in nanomedicine: fabrication and applications.
|
Nano Rev
|
2010
|
0.85
|
|
19
|
Molecular cloning and expression of the VK247 circumsporozoite protein for serodiagnosis of variant form Plasmodium vivax.
|
Parasitol Res
|
2011
|
0.84
|
|
20
|
Plasmodium vivax: comparison of the immune responses between oral and parenteral immunization of rPv54 in BALB/c mice.
|
Exp Parasitol
|
2010
|
0.84
|
|
21
|
Analysis of the dihydrofolate reductase-thymidylate synthase gene sequences in Plasmodium vivax field isolates that failed chloroquine treatment.
|
Malar J
|
2010
|
0.84
|
|
22
|
Genetic variation of aldolase from Korean isolates of Plasmodium vivax and its usefulness in serodiagnosis.
|
Malar J
|
2012
|
0.83
|
|
23
|
Rac1 is a critical mediator of endothelium-derived neurotrophic activity.
|
Sci Signal
|
2009
|
0.83
|
|
24
|
Murine immune responses to a Plasmodium vivax-derived chimeric recombinant protein expressed in Brassica napus.
|
Malar J
|
2011
|
0.82
|
|
25
|
Blocking effect of a monoclonal antibody against recombinant Pvs25 on sporozoite development in Anopheles sinensis.
|
Clin Vaccine Immunol
|
2010
|
0.81
|
|
26
|
Estimating the malaria transmission of Plasmodium vivax based on serodiagnosis.
|
Malar J
|
2012
|
0.80
|
|
27
|
Surface activation and targeting strategies of superparamagnetic iron oxide nanoparticles in cancer-oriented diagnosis and therapy.
|
Nanomedicine (Lond)
|
2010
|
0.79
|
|
28
|
The role of Pvs28 in sporozoite development in Anopheles sinensis and its longevity in BALB/c mice.
|
Exp Parasitol
|
2010
|
0.77
|
|
29
|
Comparison of the antibody responses to Plasmodium vivax and Plasmodium falciparum antigens in residents of Mandalay, Myanmar.
|
Malar J
|
2011
|
0.75
|